Literature DB >> 8403199

K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.

A A Vivona1, B Shpitz, A Medline, W R Bruce, K Hay, M A Ward, H S Stern, S Gallinger.   

Abstract

Ras mutations are an important early event in a number of carcinogen-induced rodent tumors. Colon carcinogenesis induced in rats by azoxymethane is a useful model as it mimics the adenoma-carcinoma sequence observed in humans. In addition, aberrant crypt foci develop in the rat and these lesions appear to be potentially important precursors to adenomas in colorectal cancer. Recent studies have shown that specific K-ras codon 12 and 13 mutations are present in up to 66% of carcinogen-induced rat colon adenocarcinomas. We studied the frequency of these mutations during the aberrant crypt focus-adenoma-carcinoma sequence in azoxymethane-induced Fisher F344 rats. K-ras codon 12 GAT and codon 13 GAC mutations were detected with a sensitive assay based on the amplification of DNA using the polymerase chain reaction. No mutations were present in normal mucosa. Of 27 aberrant crypt foci, K-ras mutations were identified in 2 lesions containing 5 and 10 aberrant crypts, respectively. Mutations were present in 1 of 23 and 10 of 27 adenomas and adenocarcinomas, respectively. These data suggest that K-ras mutations play a role during the stages of carcinogenesis in azoxymethane-induced rat colon cancer. The demonstration of a genetic mutation in aberrant crypt foci provides further evidence for the significance of these lesions as precursor markers of malignant potential during colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403199     DOI: 10.1093/carcin/14.9.1777

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

1.  Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors.

Authors:  Arun R Pandiri; Robert C Sills; Mark J Hoenerhoff; Shyamal D Peddada; Thai-Vu T Ton; Hue-Hua L Hong; Gordon P Flake; David E Malarkey; Greg R Olson; Igor P Pogribny; Nigel J Walker; Mary D Boudreau
Journal:  Toxicol Pathol       Date:  2011-09-21       Impact factor: 1.902

Review 2.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

3.  Decreased Expression of Retinoid X Receptors During Human and Azoxymethane-induced Colorectal Carcinogenesis in the Rat.

Authors:  Xingpei Hao; Hang Xiao; Jihyueng Ju; Stephen M Hewitt; Herbert C Morse
Journal:  Anticancer Res       Date:  2016-06       Impact factor: 2.480

4.  Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.

Authors:  Amanda J MacFarlane; Cheryll A Perry; Michael F McEntee; David M Lin; Patrick J Stover
Journal:  Carcinogenesis       Date:  2010-12-14       Impact factor: 4.944

5.  Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.

Authors:  Jun-Hua Yuan; Yan-Qing Li; Xiao-Yun Yang
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 6.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

Review 7.  Inflammation as a driver and vulnerability of KRAS mediated oncogenesis.

Authors:  Shunsuke Kitajima; Rohit Thummalapalli; David A Barbie
Journal:  Semin Cell Dev Biol       Date:  2016-06-11       Impact factor: 7.727

8.  Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032.

Authors:  Amelie Boquoi; Tina Chen; Greg H Enders
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-01

9.  Mapping six new susceptibility to colon cancer (Scc) loci using a mouse interspecific backcross.

Authors:  Chevonne D Eversley; Xie Yuying; R Scott Pearsall; David W Threadgill
Journal:  G3 (Bethesda)       Date:  2012-12-01       Impact factor: 3.154

10.  Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats.

Authors:  Rehan Khan; Abdul Quaiyoom Khan; Abdul Lateef; Muneeb U Rehman; Mir Tahir; Farrah Ali; Oday O Hamiza; Sarwat Sultana
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.